Literature DB >> 2075225

Cholinergic-adrenergic balance: Part 2. Relationship between drug sensitivity and personality.

J Fritze1, E Sofic, T Müller, H Pfüller, M Lanczik, P Riederer.   

Abstract

Sensitivity to the centrally active cholinomimetic physostigmine varies dramatically among healthy individuals. The elucidation of the reasons for this variability could contribute to the understanding of the pathophysiology of affective disorders where a cholinergic supersensitivity has been demonstrated. Therefore, personality characteristics and habitual stress-coping strategies were related to sensitivity to physostigmine in eight healthy male volunteers. Cardiovascular and behavioral responses tended to be positively correlated with irritability and emotional liability. Passive, "helpless" strategies for coping with stress were positively related to these responses. The metabolic and neuroendocrine responses to physostigmine were generally unrelated to personality. In view of putative beta-adrenergic disturbances in depression, the responses to the peripheral beta 2-adrenergic agonist reproterol were studied. Irritability and emotionality tended to be positively correlated with cardiovascular responses to reproterol as well as with reductions of heart rate by the peripheral cholinomimetic neostigmine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2075225     DOI: 10.1016/0165-1781(90)90005-p

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

1.  Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.

Authors:  J Fritze; M Lanczik; E Sofic; M Struck; P Riederer
Journal:  J Psychiatry Neurosci       Date:  1995-01       Impact factor: 6.186

2.  Equivalent EEG sources determined by FFT approximation in healthy subjects, schizophrenic and depressive patients.

Authors:  T Dierks
Journal:  Brain Topogr       Date:  1992       Impact factor: 3.020

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.